Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Linsitinib | 0.031623 | uM | 9 | 5000.00 | 2808.68 | 7103.00 | 7094.50 | 1.0012 | 1.0018 |
| BT-20 | Erlotinib | 0.031623 | uM | 9 | 5000.00 | 2808.68 | 7456.00 | 7094.50 | 1.0510 | 1.0758 |
| BT-20 | Erlotinib | 1 | uM | 9 | 5000.00 | 2808.68 | 6364.00 | 7094.50 | 0.8970 | 0.8439 |
| BT-20 | 17-AAG | 0.000302 | uM | 9 | 5000.00 | 2808.68 | 7235.00 | 7094.50 | 1.0198 | 1.0296 |
| BT-20 | Lapatinib | 3.1623 | uM | 9 | 5000.00 | 2808.68 | 5530.00 | 7094.50 | 0.7795 | 0.6599 |
| BT-20 | 17-AAG | 0.31623 | uM | 9 | 5000.00 | 2808.68 | 2070.00 | 7094.50 | 0.2918 | -0.2041 |
| BT-20 | 0 | uM | 9 | 5000.00 | 2808.68 | 6723.00 | 7094.50 | 0.9476 | 0.9211 | |
| BT-20 | 0 | uM | 9 | 5000.00 | 2808.68 | 6995.00 | 7094.50 | 0.9860 | 0.9790 | |
| BT-20 | Linsitinib | 1 | uM | 9 | 5000.00 | 2808.68 | 6548.00 | 7094.50 | 0.9230 | 0.8836 |
| BT-20 | Erlotinib | 0.31623 | uM | 9 | 5000.00 | 2808.68 | 6854.00 | 7094.50 | 0.9661 | 0.9491 |
| BT-20 | 0 | uM | 9 | 5000.00 | 2808.68 | 7045.00 | 7094.50 | 0.9930 | 0.9896 | |
| BT-20 | Linsitinib | 19.9526 | uM | 9 | 5000.00 | 2808.68 | 3957.00 | 7094.50 | 0.5578 | 0.2923 |
| BT-20 | Linsitinib | 0.0033113 | uM | 9 | 5000.00 | 2808.68 | 7047.00 | 7094.50 | 0.9933 | 0.9900 |
| BT-20 | Erlotinib | 10 | uM | 9 | 5000.00 | 2808.68 | 4417.00 | 7094.50 | 0.6226 | 0.4031 |
| BT-20 | Erlotinib | 3.1623 | uM | 9 | 5000.00 | 2808.68 | 5387.00 | 7094.50 | 0.7593 | 0.6277 |
| BT-20 | 17-AAG | 0.0031623 | uM | 9 | 5000.00 | 2808.68 | 6992.00 | 7094.50 | 0.9856 | 0.9784 |
| BT-20 | Erlotinib | 0.01 | uM | 9 | 5000.00 | 2808.68 | 7304.00 | 7094.50 | 1.0295 | 1.0440 |
| BT-20 | Linsitinib | 0.01 | uM | 9 | 5000.00 | 2808.68 | 7067.00 | 7094.50 | 0.9961 | 0.9942 |
| BT-20 | 17-AAG | 0.0001 | uM | 9 | 5000.00 | 2808.68 | 7065.00 | 7094.50 | 0.9958 | 0.9938 |
| BT-20 | 17-AAG | 0.01 | uM | 9 | 5000.00 | 2808.68 | 5583.00 | 7094.50 | 0.7870 | 0.6718 |
| BT-20 | Linsitinib | 10 | uM | 9 | 5000.00 | 2808.68 | 5480.00 | 7094.50 | 0.7724 | 0.6487 |
| BT-20 | 0 | uM | 9 | 5000.00 | 2808.68 | 7057.00 | 7094.50 | 0.9947 | 0.9921 | |
| BT-20 | Lapatinib | 1 | uM | 9 | 5000.00 | 2808.68 | 6856.00 | 7094.50 | 0.9664 | 0.9495 |
| BT-20 | Lapatinib | 10 | uM | 9 | 5000.00 | 2808.68 | 2824.00 | 7094.50 | 0.3981 | 0.0041 |
| BT-20 | Lapatinib | 0.0033113 | uM | 9 | 5000.00 | 2808.68 | 7263.00 | 7094.50 | 1.0238 | 1.0354 |